Collectively, these observations suggest that the abundant and widespread expression of several different immune checkpoint systems beyond PD-1 and CTLA-4 may act to suppress T cell activation in the context of the ccRCC microenvironment. This evidence concerns the gene CTLA4 and nonpapillary renal cell carcinoma.